 Connection
Pamela Peterson to Anti-Arrhythmia Agents
This is a "connection" page, showing publications Pamela Peterson has written about Anti-Arrhythmia Agents.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.697 |
|
|
|
-
Peterson PN, Varosy PD. Observational comparative effectiveness research: comparative effectiveness and caveat emptor. Circ Cardiovasc Qual Outcomes. 2012 Mar 01; 5(2):150-2.
Score: 0.379
-
Hess PL, Sheng S, Matsouaka R, DeVore AD, Heidenreich PA, Yancy CW, Bhatt DL, Allen LA, Peterson PN, Ho PM, Lewis WR, Hernandez AF, Fonarow GC, Piccini JP. Strict Versus Lenient Versus Poor Rate Control Among Patients With Atrial Fibrillation and Heart Failure (from the Get With The Guidelines - Heart Failure Program). Am J Cardiol. 2020 03 15; 125(6):894-900.
Score: 0.163
-
Dev S, Peterson PN, Wang Y, Curtis JP, Varosy PD, Masoudi FA. Prevalence, correlates, and temporal trends in antiarrhythmic drug use at discharge after implantable cardioverter defibrillator placement (from the National Cardiovascular Data Registry [NCDR]). Am J Cardiol. 2014 Jan 15; 113(2):314-20.
Score: 0.106
-
Patel RB, Greene SJ, Xu H, Alhanti B, Peterson P, Yancy CW, Piccini J, Fonarow GC, Vaduganathan M. Intersection of atrial fibrillation and heart failure with mildly reduced and preserved ejection fraction in >400 000 participants in the Get With The Guidelines-Heart Failure Registry. Eur J Heart Fail. 2023 01; 25(1):63-73.
Score: 0.050
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|